# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Benjamin Franklin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN004-SYN-TD
- Date: 1782-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lydia Penhallow, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- Painful, interrupted urination and blood in the urine after car journeys **S**
- Gout flares keep confining him to his chair, and he does not want to give up wine and good dinners entirely **S**

## Your goals

- Serum urate below 6 mg/dL on allopurinol by the six-month review. Target: 1782-09-14. Recorded outcome: Serum urate 5.4 mg/dL on allopurinol 300 mg. **S**
- Bladder stone removed and comfortable voiding with a normal post-void residual. Target: 1782-05-18. Recorded outcome: Stone removed; IPSS from 16 to 6; residual 35 mL. **S**
- No gout flare for six months after starting urate-lowering therapy. Target: 1782-09-14. Recorded outcome: Not met: one knee flare in July while urate was still above target; none since. **S**
- Blood pressure below 130/80 without dizziness. Target: 1782-09-14. Recorded outcome: 128/76 mmHg on losartan. **S**
- Urine output of at least 2.5 L a day and urine pH of 6.0 to 6.5. Target: 1782-09-14. Recorded outcome: Urine pH 6.3 on potassium citrate; home measuring jug shows about 2.3 L a day. **S**

## What we agreed to do

- Start allopurinol 100 mg daily and raise it by 100 mg every 2 to 5 weeks until serum urate is below 6 mg/dL; HLA-B*58:01 testing is not indicated, because he is not of Southeast Asian or African ancestry. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020) **S**
- Colchicine 0.6 mg daily for three to six months as flare prophylaxis; treat flares with a short prednisone course or extra colchicine, and avoid NSAIDs because of chronic kidney disease. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026) **S**
- Replace hydrochlorothiazide with losartan, which lowers blood pressure and slightly lowers urate; check potassium and creatinine 2 to 4 weeks after starting. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020); 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026) **S**
- Urology referral to confirm and remove the bladder stone, look for bladder outlet obstruction and other causes of hematuria, and advise on stone prevention. Guideline: Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019); EAU Guidelines on Urolithiasis (including bladder stones) (2025); Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2023 amendment) **S**
- Uric acid stone prevention: fluids for a urine output of at least 2.5 L a day, potassium citrate to a urine pH of 6.0 to 6.5, stone analysis, and a 24-hour urine collection. Guideline: Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019); EAU Guidelines on Urolithiasis (including bladder stones) (2025) **S**
- CMID kidney and blood pressure monitoring: blood pressure every visit; eGFR and urine albumin yearly at G3a A1; calcium, phosphate, and PTH at baseline; hemoglobin and the kidney failure risk equation yearly; statin for age over 50 with eGFR below 60; medication review for NSAIDs every visit. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026) **S**
- Limit alcohol, especially beer and spirits, and purine-rich meat, organ meat, and shellfish; avoid sugar-sweetened drinks; aim for gradual weight loss and daily walking. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020) **S**

## Follow-up

- 1782-03-02: Primary care visit for recurrent gout flares and painful, interrupted urination with blood in the urine **S**
- 1782-03-30: Four-week gout and blood pressure review, with urology consultation for a bladder stone **S**
- 1782-05-18: Review four weeks after stone removal and prostate resection, with urate titration and stone metabolic evaluation **S**
- 1782-09-14: Gout, stone prevention, kidney, and blood pressure review at about six months **S**
- 1782-10-19: Subsequent annual wellness visit **S**

This teaching document does not replace care from a qualified clinician.
